Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1997 Mar;62(3):239–242. doi: 10.1136/jnnp.62.3.239

Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.

F Federico 1, I L Simone 1, V Lucivero 1, M De Mari 1, P Giannini 1, G Iliceto 1, D M Mezzapesa 1, P Lamberti 1
PMCID: PMC1064152  PMID: 9069478

Abstract

OBJECTIVES: Proton magnetic resonance spectroscopy (1H-MRS) localised to the lentiform nucleus, was carried out in eight patients with idiopathic Parkinson's disease and five patients with progressive supranuclear palsy. The aim of the study was to assess the concentration of N-acetyl-aspartate (NAA), creatine and phosphocreatine (Cr), and choline containing compounds (Cho) in the putamen and globus pallidus of these patients. METHODS: Peak ratios obtained from patients were compared with those from nine healthy age matched controls. RESULTS: NAA/Cho and NAA/Cr ratios were reduced significantly in patients with progressive supranuclear palsy. CONCLUSION: These results suggest an NAA deficit, due to neuronal loss, in the lentiform nucleus of these patients. 1H-MRS is a non-invasive technique that can provide useful information concerning striatal neuronal loss in the basal ganglia of patients with parkinsonian syndromes.

Full text

PDF
239

Images in this article

240Image
on p.240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agid Y. Parkinson's disease: pathophysiology. Lancet. 1991 Jun 1;337(8753):1321–1324. doi: 10.1016/0140-6736(91)92989-f. [DOI] [PubMed] [Google Scholar]
  2. Arnold D. L., Matthews P. M., Francis G. S., O'Connor J., Antel J. P. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol. 1992 Mar;31(3):235–241. doi: 10.1002/ana.410310302. [DOI] [PubMed] [Google Scholar]
  3. Barker P. B., Lee R. R., McArthur J. C. AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology. 1995 Apr;195(1):58–64. doi: 10.1148/radiology.195.1.7892496. [DOI] [PubMed] [Google Scholar]
  4. Bruhn H., Michaelis T., Merboldt K. D., Hänicke W., Gyngell M. L., Hamburger C., Frahm J. On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro. NMR Biomed. 1992 Sep-Oct;5(5):253–258. doi: 10.1002/nbm.1940050510. [DOI] [PubMed] [Google Scholar]
  5. Chang L., Miller B. L., McBride D., Cornford M., Oropilla G., Buchthal S., Chiang F., Aronow H., Beck C. K., Ernst T. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology. 1995 Nov;197(2):525–531. doi: 10.1148/radiology.197.2.7480706. [DOI] [PubMed] [Google Scholar]
  6. Collins S. J., Ahlskog J. E., Parisi J. E., Maraganore D. M. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):167–173. doi: 10.1136/jnnp.58.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davie C. A., Pirtosek Z., Barker G. J., Kingsley D. P., Miller P. H., Lees A. J. Magnetic resonance spectroscopic study of parkinsonism related to boxing. J Neurol Neurosurg Psychiatry. 1995 Jun;58(6):688–691. doi: 10.1136/jnnp.58.6.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davie C. A., Wenning G. K., Barker G. J., Tofts P. S., Kendall B. E., Quinn N., McDonald W. I., Marsden C. D., Miller D. H. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol. 1995 Feb;37(2):204–210. doi: 10.1002/ana.410370211. [DOI] [PubMed] [Google Scholar]
  9. Federico F., Simone I. L., Conte C., Lucivero V., Giannini P., Liguori M., Picciola E., Tortorella C. Prognostic significance of metabolic changes detected by proton magnetic resonance spectroscopy in ischaemic stroke. J Neurol. 1996 Mar;243(3):241–247. doi: 10.1007/BF00868521. [DOI] [PubMed] [Google Scholar]
  10. Felber S. R., Aichner F. T., Sauter R., Gerstenbrand F. Combined magnetic resonance imaging and proton magnetic resonance spectroscopy of patients with acute stroke. Stroke. 1992 Aug;23(8):1106–1110. doi: 10.1161/01.str.23.8.1106. [DOI] [PubMed] [Google Scholar]
  11. Frahm J., Bruhn H., Gyngell M. L., Merboldt K. D., Hänicke W., Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med. 1989 Jul;11(1):47–63. doi: 10.1002/mrm.1910110105. [DOI] [PubMed] [Google Scholar]
  12. Frahm J., Michaelis T., Merboldt K. D., Hänicke W., Gyngell M. L., Bruhn H. On the N-acetyl methyl resonance in localized 1H NMR spectra of human brain in vivo. NMR Biomed. 1991 Aug;4(4):201–204. doi: 10.1002/nbm.1940040408. [DOI] [PubMed] [Google Scholar]
  13. Fulham M. J., Bizzi A., Dietz M. J., Shih H. H., Raman R., Sobering G. S., Frank J. A., Dwyer A. J., Alger J. R., Di Chiro G. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology. 1992 Dec;185(3):675–686. doi: 10.1148/radiology.185.3.1438744. [DOI] [PubMed] [Google Scholar]
  14. Gideon P., Henriksen O., Sperling B., Christiansen P., Olsen T. S., Jørgensen H. S., Arlien-Søborg P. Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study. Stroke. 1992 Nov;23(11):1566–1572. doi: 10.1161/01.str.23.11.1566. [DOI] [PubMed] [Google Scholar]
  15. Golbe L. I., Davis P. H., Schoenberg B. S., Duvoisin R. C. Prevalence and natural history of progressive supranuclear palsy. Neurology. 1988 Jul;38(7):1031–1034. doi: 10.1212/wnl.38.7.1031. [DOI] [PubMed] [Google Scholar]
  16. Gouider-Khouja N., Vidailhet M., Bonnet A. M., Pichon J., Agid Y. "Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study. Mov Disord. 1995 May;10(3):288–294. doi: 10.1002/mds.870100310. [DOI] [PubMed] [Google Scholar]
  17. Holshouser B. A., Komu M., Möller H. E., Zijlmans J., Kolem H., Hinshaw D. B., Jr, Sonninen P., Vermathen P., Heerschap A., Masur H. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magn Reson Med. 1995 May;33(5):589–594. doi: 10.1002/mrm.1910330502. [DOI] [PubMed] [Google Scholar]
  18. Jenkins B. G., Koroshetz W. J., Beal M. F., Rosen B. R. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology. 1993 Dec;43(12):2689–2695. doi: 10.1212/wnl.43.12.2689. [DOI] [PubMed] [Google Scholar]
  19. Matthews P. M., Francis G., Antel J., Arnold D. L. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology. 1991 Aug;41(8):1251–1256. doi: 10.1212/wnl.41.8.1251. [DOI] [PubMed] [Google Scholar]
  20. Miller B. L. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed. 1991 Apr;4(2):47–52. doi: 10.1002/nbm.1940040203. [DOI] [PubMed] [Google Scholar]
  21. Shonk T. K., Moats R. A., Gifford P., Michaelis T., Mandigo J. C., Izumi J., Ross B. D. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology. 1995 Apr;195(1):65–72. doi: 10.1148/radiology.195.1.7892497. [DOI] [PubMed] [Google Scholar]
  22. Vion-Dury J., Meyerhoff D. J., Cozzone P. J., Weiner M. W. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol. 1994 May;241(6):354–371. doi: 10.1007/BF02033352. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES